Literature DB >> 8874752

Interleukin-1 beta upregulates tissue-type plasminogen activator in a keratinocyte cell line (HaCaT).

J M Rox1, J Reinartz, M D Kramer.   

Abstract

Human keratinocytes synthesize and secrete tissue-type plasminogen activator (tPA). tPA converts the inactive precursor enzyme plasminogen into the trypsin-like proteinase plasmin. tPA is not found in normal epidermis, but in lesional epidermis from patients with a variety of cutaneous diseases, including psoriasis, pemphigus and pemphigoid. The presence of tPA is probably a reaction to the disease process rather than the initiating event in these etiologically and histopathologically diverse lesions. However, the factor(s) that upregulate tPA expression and secretion in keratinocytes have remained largely elusive. We sought to determine whether the inflammatory cytokine interleukin-1 beta (IL-1 beta), which is commonly present in diverse epidermal lesions, influences tPA production. Accordingly, we studied the influence of IL-1 beta on secretion of tPA by cells of the human keratinocyte cell line HaCaT. We found that IL-1 beta increased tPA secretion in these cells. Given the observation that IL-1 beta is a common proinflammatory mediator in cutaneous diseases, our findings may explain the increase in tPA in clinically and etiologically diverse inflammatory epidermal lesions.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8874752     DOI: 10.1007/bf02505254

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  35 in total

1.  Plasminogen binding sites in normal human skin.

Authors:  S M Burge; J M Marshall; S A Cederholm-Williams
Journal:  Br J Dermatol       Date:  1992-01       Impact factor: 9.302

Review 2.  The plasminogen activator/plasmin system.

Authors:  J D Vassalli; A P Sappino; D Belin
Journal:  J Clin Invest       Date:  1991-10       Impact factor: 14.808

3.  A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes.

Authors:  N A Thornberry; H G Bull; J R Calaycay; K T Chapman; A D Howard; M J Kostura; D K Miller; S M Molineaux; J R Weidner; J Aunins
Journal:  Nature       Date:  1992-04-30       Impact factor: 49.962

Review 4.  Biology of the interleukin-1 receptor.

Authors:  S K Dower; E E Qwarnstrom; R C Page; R A Blanton; T S Kupper; E Raines; R Ross; J E Sims
Journal:  J Invest Dermatol       Date:  1990-06       Impact factor: 8.551

5.  Cloning of cDNA coding for human tissue-type plasminogen activator and its expression in Escherichia coli.

Authors:  T J Harris; T Patel; F A Marston; S Little; J S Emtage; G Opdenakker; G Volckaert; W Rombauts; A Billiau; P De Somer
Journal:  Mol Biol Med       Date:  1986-06

6.  Plasminogen activator in cultured human epidermal cells.

Authors:  K Hashimoto; K H Singer; W B Lide; K Shafran; P Webber; S Morioka; G S Lazarus
Journal:  J Invest Dermatol       Date:  1983-11       Impact factor: 8.551

7.  mRNA for tissue-type plasminogen activator is present in lesional epidermis from patients with psoriasis, pemphigus, or bullous pemphigoid, but is not detected in normal epidermis.

Authors:  J Baird; G S Lazarus; D Belin; J D Vassalli; N Busso; P Gubler; P J Jensen
Journal:  J Invest Dermatol       Date:  1990-11       Impact factor: 8.551

8.  Immunohistochemical characterization of the plasminogen activator system in psoriatic epidermis.

Authors:  H M Gissler; R Frank; M D Kramer
Journal:  Br J Dermatol       Date:  1993-06       Impact factor: 9.302

9.  Generation of biologically active interleukin-1 beta by proteolytic cleavage of the inactive precursor.

Authors:  R A Black; S R Kronheim; M Cantrell; M C Deeley; C J March; K S Prickett; J Wignall; P J Conlon; D Cosman; T P Hopp
Journal:  J Biol Chem       Date:  1988-07-05       Impact factor: 5.157

10.  Toxicity determined in vitro by morphological alterations and neutral red absorption.

Authors:  E Borenfreund; J A Puerner
Journal:  Toxicol Lett       Date:  1985 Feb-Mar       Impact factor: 4.372

View more
  2 in total

1.  Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes.

Authors:  E Schmidt; B Wehr; E M Tabengwa; S Reimer; E-B Bröcker; D Zillikens
Journal:  Clin Exp Immunol       Date:  2004-03       Impact factor: 4.330

2.  Innate immune activation as cofactor in pemphigus disease manifestation.

Authors:  Ramona A Eichkorn; Morna F Schmidt; Elias Walter; Michael Hertl; Jens Malte Baron; Jens Waschke; Amir S Yazdi
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.